The present invention relates to a pharmaceutical composition for preventing or treating osteoporosis comprising exosomes isolated from adipose tissue-derived stem cells as an active ingredient. The exosomes isolated from the adipose tissue-derived stem cells according to the present invention can facilitate osteogenesis and enhance bone density, and therefore it can be useful for prevention or treatment of osteoporosis.
